Global Health Data Exchange - Discover the World's Health Data

Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)

Nav

General Info
Geography 
Australia (AUS)
Time period covered 
01/1996 - 12/1999